在晚期乳腺癌中进行5天,1天和2天周期性组合化疗的比较
Lancet (London, England)
|August 2, 1975
概括
晚期乳腺癌的5天化疗方案显示出比1天方法更好的瘤回归. 然而,两天疗程可能比五天疗程更有效,这表明乳腺癌治疗的最佳化疗计划.
科学领域:
- 在瘤学瘤学.
- 医疗治疗协议 医疗治疗协议
背景情况:
- 晚期乳腺癌需要有效的化疗.
- 为了优化治疗,比较不同的化疗施用时间表至关重要.
研究的目的:
- 为了比较5天循环组合化疗方案与1天和2天治疗方案对晚期乳腺癌的疗效.
- 为了评估不同治疗持续时间的瘤回归和缓解率.
主要方法:
- 进行了两项临床试验,比较化疗方案.
- 该研究评估了5天,1天和2天治疗计划的结果.
- 瘤回归和缓解是初级疗效终点.
主要成果:
- 5天的治疗方案在实现瘤回归和缓解方面明显比1天的治疗方案更有效,除了3个月的标志.
- 两天疗程与五天疗程相比,显示出更高效率的趋势,尽管在统计学上并不显著.
- 2天治疗成功的下一个95%置信限为3个月后的56.2%.
结论:
- 5天循环化疗是晚期乳腺癌的可行选择,效果优于1天的疗法.
- 两天疗程需要进一步研究,因为它可能是比五天疗程更有效的替代方案.
- 优化化疗计划可能会改善晚期乳腺癌治疗的结果.
相关概念视频
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...